Latest news

A pharmaceutical future

Clear blue liquid in petri dish

Fucoidans are increasingly being utilised for advanced pharmaceutical research. Not only are they known for their diverse range of bioactivities - including anti-inflammatory, antiviral, immunomodulatory, antioxidant and antitumorigenic effects - but also as nanocarriers for targeted drug delivery. 

Marinova is actively collaborating with both research institutions and commercial enterprises. The company has the expertise and capability to develop and produce high purity fucoidan extracts for a wide range of advanced applications. Marinova is experienced in creating novel compounds for very specific purposes, from biomaterials research through to medical devices and pharmaceutical development.

"Marinova has a successful track record in developing unique fucoidan extracts for a range of pharmaceutical research applications. These include innovative studies exploring potential future adjunct therapies and medical devices," explained the company's Research Director, Dr Barbara Wimmer. "It is exciting to see many of these projects now advancing to clinical trials. The volume of pharmaceutical research being published involving Marinova's ultra high purity fucoidans reflects the global shift towards the development of effective new therapeutics from natural bioactive compounds." 

 

News index